Organization Overview
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
Bivalent group A and C meningococcal vaccine (Menomune-A/C) (1 trial)
haemophilus influenzae type b conjugate vaccine (HibTITER) (2 trials)
inactivated SARS-Cov-2 vaccine (5 trials)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (1 trial)
Haemophilus Infections (Phase 3)
Influenza, Human (Phase 3)
Meningitis (Phase 3)
Pneumonia (Phase 3)
Postpoliomyelitis Syndrome (Phase 2)
Rabies (Phase 3)